Antigen-specific T-cell immune responses can be achieved by modifying TCR to express tumor antigen-specificα and β chains and thereby programming T cells to recognize HCC-specific antigens such as AFP, hTERT, MAGE, and NY-ESO-1 [142,143,144,145]. Here, AFP is linked to hepatocellular carcinoma.